Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Arcutis Biotherapeutics, Inc.
Updated Jul 16, 2026
LIN SUE-JEAN has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $121K.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-26 | STVN | Stevanato Group S.p.A. | A — Grant or award | 5.0K | $0.00 | |
| 2026-06-18 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 4.9K | $24.38 | $121K |
| 2026-06-10 | ARQT | Arcutis Biotherapeutics, Inc. | A — Grant or award | 5.8K | $0.00 |
LIN SUE-JEAN is a corporate insider — currently tracked as Insider of Stevanato Group S.p.A. (STVN). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($121K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LIN SUE-JEAN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.